Invention Grant
- Patent Title: Neurotoxic target for amylospheroid, method and material for reducing the neurotoxicity of amylospheroid, and use thereof
-
Application No.: US13729152Application Date: 2012-12-28
-
Publication No.: US09751912B2Publication Date: 2017-09-05
- Inventor: Minako Hoshi
- Applicant: TAO Health Life Pharma Co., Ltd.
- Applicant Address: JP Kyoto
- Assignee: TAO HEALTH LIFE PHARMA CO., LTD.
- Current Assignee: TAO HEALTH LIFE PHARMA CO., LTD.
- Current Assignee Address: JP Kyoto
- Agency: Wenderoth, Lind & Ponack, L.L.P.
- Priority: JP2012-002448 20120110
- Main IPC: A61K51/08
- IPC: A61K51/08 ; A61K38/13 ; A61K38/00 ; C07K5/117 ; A61K38/17 ; A61K31/554 ; G01N33/68 ; C07K7/06 ; C07K7/08 ; C07K5/107 ; C07K5/11

Abstract:
In one or a plurality of embodiments, there is provided a target molecule of amylospheroid, which is expressed in mature neurons and to which the amylospheroid binds to induce death of cells. Further, in one or a plurality of embodiments, there is provided a method and a substance for inhibiting death of mature neurons induced by the amylospheroid. In one aspect, the present disclosure relates to a use of Na+/K+-ATPase α3 as a binding target molecule of amylospheroid. In another aspect, the present disclosure relates to a method for suppressing death of mature neurons induced by the amylospheroid, including inhibiting protein-protein interaction between the amylospheroid and the Na+/K+-ATPase α3, and the like.
Public/Granted literature
Information query